Aceso Life Science Group Ltd - Company Profile

Powered by

All the data and insights you need on Aceso Life Science Group Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Aceso Life Science Group Ltd Strategy Report

  • Understand Aceso Life Science Group Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Aceso Life Science Group Ltd: Overview

Aceso Life Science Group Ltd (Aceso Life), formerly Hao Tian Development Group Limited, is an investment holding company. It offers financial services such as money lending, investment, and trading services through its subsidiaries. The company provides personal loans and property mortgage loans and related financial advisory solutions. It involves securities investment, brokerage, commodities, and futures services. The company expanded into the business of bioscience and it completed its first round of fundraising towards Promethera Biosciences S.A/N.V. and established a joint venture with Promethera Biosciences, called Aceso-Promethera Asia Company Limited. The company also carries out rental and trading of construction machinery, property leasing, and retailing of men’s and women’s apparel. It serves the cultural and creative, consumer real estate and financial technology industries. It has operations in Hong Kong, Macau, Cambodia, and the UK. The company is a subsidiary of Asia Link Capital Investment Holding Ltd. Aceso Life is headquartered in Hong Kong.

Gain a 360-degree view of Aceso Life Science Group Ltd and make more informed decisions for your business Gain a 360-degree view of Aceso Life Science Group Ltd and make more informed decisions for your business Find out more
Headquarters Hong Kong

Address Rooms 2501–2509, 25/F, Shui On Centre, 6–8 Harbour Road, Hong Kong City


Telephone 852 31608466

No of Employees 142

Industry Financial Services

Ticker Symbol & Exchange 474 (HKG)

Revenue (2022) $39.8M -1% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 28.6% (2022 vs 2021)

Market Cap* $146.1M

Net Profit Margin (2022) XYZ 28.0% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Aceso Life Science Group Ltd premium industry data and analytics

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Aceso Life Science Group Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services
Personal Loans Securities Investment Services
Mortgage Securities Trading
Apparel Property Investment
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Aceso Life Science Group Ltd portfolio and identify potential areas for collaboration Understand Aceso Life Science Group Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Aceso Life Science Group Ltd Allied Group Ltd APAC Resources Limited Goldbond Group Holdings Limited First Credit Finance Group Limited
Headquarters Hong Kong Hong Kong Hong Kong Hong Kong Hong Kong
City Hong Kong City Hong Kong Hong Kong Hong Kong Hong Kong
No. of Employees 142 3,545 25 117 12
Entity Type Public Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Fok Chi Tak Director; Chief Financial Officer Executive Board 2013 47
Zhiliang Ou Director Executive Board 2012 54
Siu Chun Pong Raymond Secretary Senior Management 2022 42
Lam Kwan Sing Director Non Executive Board 2012 53
Chan Ming Sun Jonathan Director Non Executive Board 2012 50
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Aceso Life Science Group Ltd key executives to enhance your sales strategy Gain insight into Aceso Life Science Group Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code